NCT03933930撤回不适用
Comparing the Prognosis of Lactate-directed and Goal-directed Therapy in Hyperthermic Intraperitoneal Chemotherapy.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 主要终点
- pulmonary complication
研究概览
简要总结
Hyperthermic intraperitoneal chemotherapy is a major surgery for tumor peritoneal metastasis. For anesthesiologist, the intra-operative fluid control is always a big challenge. We try to compare the prognosis of lactate-directed and goal-directed therapy. We expect to confirm the better prognosis of lactate-directed therapy.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Triple (Participant, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 20 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients receiving hyperthermic intraperitoneal chemotherapy
排除标准
- •Unable to set arterial line Severe liver or renal disease Severe heart disease Unconscious patients
结局指标
主要结局
pulmonary complication
时间窗: 1 week
X-ray findings of airspace or interstitial opacity, lobar consolidation, or pleural effusions; severe respiratory failure requiring respiratory support
次要结局
- Renal complication(1 week)
研究者
anchihhsu
Principal Investigator
Taipei Medical University WanFang Hospital
相似试验
终止
不适用
Hyperthermic Intraoperative Intraperitoneal Chemotherapy of Recurrent Ovarian Cancer - A Feasibility StudyEpithelial Ovarian CancerFallopian Tube CarcinomaNCT00968799Cantonal Hospital of St. Gallen6
尚未招募
2 期
HIPEC Combined With SOX and Sintilimab in the Treatment of Advanced Gastric Cancer With Peritoneal MetastasisPeritoneal MetastasesGastric CancerNCT06213519Sichuan University69
已完成
2 期
Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Metastatic Gastric CancerGastrointestinal CancerNCT02092298M.D. Anderson Cancer Center21
Unknown
2 期
Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian CarcinomaEpithelial Ovarian CarcinomaFigo Stage IIICNCT00349505Gustave Roussy, Cancer Campus, Grand Paris67
进行中（未招募）
不适用
Surgery plus intraperitoneal Hypertermic chemotherapy in platinum-sensitive patients with ovarian cancer recurrence after 12 months. Phase II studyRecurrent ovarian cancerMedDRA version: 6.1Level: PTClassification code 10033128EUCTR2005-000927-41-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI